ARIAD Pharmaceuticals, Inc. (ARIA) Jefferies 2014 Global Healthcare Conference June 4, 2014 2:30 PM ET Executives Tim Clackson - President of Research and Development and CSO Analysts Eun Yang - Jefferies Eun Yang Good afternoon. This is Eun Yang, a biotech analyst with Jefferies. So, next presenting company is ARIAD Pharmaceuticals. ARIAD is a cancer -- largely, primarily focused on cancer and has one product on the market Iclusig, and then second product entering Phase 3 shortly. So fresh, coming out of the fresh, out of ASCO fresher Tim Clackson is the one representing from ARIAD Pharmaceuticals. And Tim is the President of Research & Development at ARIAD. Tim? Tim Clackson Thank you Eun, it's a pleasure to be here and to give you -- yes a very fresh update on the data that we presented at ASCO. More generally on the progress that ARIAD is making across our various different programs.